Clinical Study
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
Table 5
Comparison of the outcomes in the APD and OPD arms.
| | Outcome | APD arm | OPD arm |
| | Number of cycles received | 6 | 6 | | CR rates | 80% | 78% | | Emesis | | | | Acute emesis | 7 (14%) | 8 (16%) | | Delayed emesis | 7 (14%) | 6 (12%) | | Overall emesis | 10 (20%) | 11 (78%) | | Nausea | | | | Acute nausea | 6 (12%) | 8 (16%) | | Delayed nausea | 8 (16%) | 6 (12%) | | Overall nausea | 8 (16%) | 8 (16%) |
|
|
